Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP3 | P15309 | 1/20 | 0.50 |
| ▸ | MMP1 | P03956 | 2/20 | 0.45 |
| ▸ | MMP13 | P45452 | 2/20 | 0.45 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.41 |
| ▸ | PGK1 | P00558 | 3/20 | 0.40 |
| ▸ | PGK2 | P07205 | 3/20 | 0.40 |
| ▸ | ANPEP | P15144 | 2/20 | 0.40 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.40 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5054247 | 0.86 | ACP3 (0.45) | ACP3MMP1MMP13 | |
| SCHEMBL8064038 | 0.85 | SMN1; SMN2 (0.48) | MMP1MMP13 | |
| SCHEMBL5054404 | 0.80 | CYP1A2 (0.41) | PIN1 | |
| SCHEMBL5054385 | 0.77 | FOLH1 (0.55) | — | |
| SCHEMBL7608381 | 0.77 | ANPEP (0.43) | ANPEPERAP2ERAP1 | |
| SCHEMBL5059745 | 0.77 | GAA (0.46) | ANPEPERAP2ERAP1 | |
| SCHEMBL8061513 | 0.77 | MMP1 (0.44) | MMP1MMP13 | |
| SCHEMBL8064170 | 0.76 | ACP3 (0.51) | ACP3MMP1MMP13 | |
| SCHEMBL5054530 | 0.76 | FDPS (0.48) | ANPEPERAP2ERAP1 | |
| SCHEMBL8061523 | 0.75 | ACP3 (0.49) | ACP3PIN1PGK1PGK2TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6046180-A | NAALADase inhibitors | GUILFORD PHARMACEUTICALS INC. (US) | 2000-04-04 | — | — | US | disclosed |
| EP-0936914-A4 | — | — | 1999-08-25 | — | — | EP | disclosed |
| EP-0936914-A1 | HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS | GUILFORD PHARMACEUTICALS INC. (US) | 1999-08-25 | — | — | EP | disclosed |
| WO-1997048400-A1 | HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS | GUILFORD PHARMACEUTICALS INC. (US) | 1997-12-24 | — | — | WO | disclosed |